ZIMMER BIOMET HOLDINGS, INC. Research and Development Expense
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Research and Development Expense of $53.50 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2013-05-08
- ZIMMER BIOMET HOLDINGS, INC. research and development expense for the quarter ending 2013-03-31 was $53.50M, a 10.23% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. research and development expense for the quarter ending 2012-12-31 was $55.30M, a 14.79% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. research and development expense for the quarter ending 2012-09-30 was $53.50M, a 12.30% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. research and development expense for the quarter ending 2012-03-31 was $59.60M.
- ZIMMER BIOMET HOLDINGS, INC. research and development expense for fiscal 2012 was $225.60M, a 5.37% decline from fiscal 2011.
- ZIMMER BIOMET HOLDINGS, INC. research and development expense for fiscal 2011 was $238.40M, a 9.11% increase from fiscal 2010.
- ZIMMER BIOMET HOLDINGS, INC. research and development expense for fiscal 2010 was $218.50M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2013-03-31 | $53.50M 10-Q · filed 2013-05-08 | $108.80M derived: sum of 2 quarters · filed 2013-05-08 | $162.30M derived: sum of 3 quarters · filed 2013-05-08 | |
| 2012-12-31 | $55.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $108.80M derived: sum of 2 quarters · filed 2013-02-27 | $225.60M 10-K · filed 2013-02-27 | |
| 2012-09-30 | $53.50M 10-Q · filed 2012-11-06 | $170.30M 10-Q · filed 2012-11-06 | ||
| 2012-03-31 | $59.60M 10-Q · filed 2013-05-08 | $124.50M derived: sum of 2 quarters · filed 2013-05-08 | $185.50M derived: sum of 3 quarters · filed 2013-05-08 | |
| 2011-12-31 | $64.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $125.90M derived: sum of 2 quarters · filed 2013-02-27 | $238.40M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $61.00M 10-Q · filed 2012-11-06 | $173.50M 10-Q · filed 2012-11-06 | ||
| 2010-12-31 | $218.50M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |